Predictors of relapse in a fixed-dose, randomized, double-blind, 52-week relapse prevention trial of selegiline transdermal system

被引：0
|
作者：
Patkar, A. [1 ]
Jang, S. [1 ]
Jung, S. [1 ]
Pae, C. [1 ]
Jae, Y. [1 ]
Portland, K. [2 ]
机构：
[1] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
[2] Dey Pharma LP, Med Affairs, Basking Ridge, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70380-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [31] Effects of ruxolitinib cream on affected body areas in patients with vitiligo: Subgroup analysis from a 52-week, randomized, double-blind trial
    Grimes, Pearl
    Rosmarin, David
    Hamzavi, Iltefat
    Harris, John E.
    Lebwohl, Mark
    Gottlieb, Alice B.
    Butler, Kathleen A.
    Kuo, Fiona I.
    Sun, Kang
    Pandya, Amit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB197 - AB197
  • [32] Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence
    Elkashef, Ahmed
    Fudala, Paul J.
    Gorgon, Liza
    Li, Shou-Hua
    Kahn, Roberta
    Chiang, Nora
    Vocci, Frank
    Collins, Joseph
    Jones, Karen
    Boardman, Kathy
    Sather, Mike
    DRUG AND ALCOHOL DEPENDENCE, 2006, 85 (03) : 191 - 197
  • [33] Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison
    Keefe, Richard S. E.
    Sweeney, John A.
    Gu, Hongbin
    Hamer, Robert M.
    Perkins, Diana O.
    McEvoy, Joseph P.
    Lieberman, Jeffrey A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (07): : 1061 - 1071
  • [34] Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison
    McEvoy, Joseph P.
    Lieberman, Jeffrey A.
    Perkins, Diana O.
    Hamer, Robert M.
    Gu, Hongbin
    Lazarus, Arthur
    Sweitzer, Dennis
    Olexy, Christina
    Weiden, Peter
    Strakowski, Stephen D.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (07): : 1050 - 1060
  • [35] A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
    Kane, John M.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    SCHIZOPHRENIA RESEARCH, 2015, 164 (1-3) : 127 - 135
  • [36] PREVENTION OF DUODENAL-ULCER RELAPSE BY CIMETIDINE - ONE-YEAR DOUBLE-BLIND TRIAL
    HETZEL, DJ
    SHEARMAN, DJC
    HECKER, R
    SHEERS, R
    MEDICAL JOURNAL OF AUSTRALIA, 1979, 1 (11) : 529 - 531
  • [37] Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial
    Phillips, Katharine A.
    Keshaviah, Aparna
    Dougherty, Darin D.
    Stout, Robert L.
    Menard, William
    Wilhelm, Sabine
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (09): : 887 - 895
  • [38] PREVENTION OF RELAPSE OF DUODENAL-ULCER BY BEDTIME CIMETIDINE A DOUBLE-BLIND CLINICAL-TRIAL
    BLACKWOOD, WS
    MAUDGAL, DP
    NORTHFIELD, TC
    GUT, 1977, 18 (05) : A420 - A420
  • [39] Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial
    Allen, Sharon S.
    Allen, Alicia M.
    Lunos, Scott
    Tosun, Nicole
    NICOTINE & TOBACCO RESEARCH, 2016, 18 (11) : 2145 - 2153
  • [40] Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial
    Tohen, M
    Marneros, A
    Bowden, C
    Greil, W
    Koukopoulis, A
    Belmaker, H
    Jacobs, T
    Baker, RW
    Williamson, D
    Evans, AR
    Dossenbach, M
    McGee, D
    Cassano, G
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A22 - A22
12345